BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15805744)

  • 1. Clinicopathological survey of 101 canine mammary gland tumors: differences between small-breed dogs and others.
    Itoh T; Uchida K; Ishikawa K; Kushima K; Kushima E; Tamada H; Moritake T; Nakao H; Shii H
    J Vet Med Sci; 2005 Mar; 67(3):345-7. PubMed ID: 15805744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidentally diagnosed mammary gland tumors are less likely to be malignant than nonincidental mammary gland tumors.
    Murphy CB; Hoelzler MG; Newgent AR; Botchway A
    J Am Vet Med Assoc; 2023 Oct; 261(10):1-6. PubMed ID: 37400074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
    Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
    Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and pathological prognostic factors in canine mammary tumors.
    Pérez Alenza MD; Peña L; Nieto AI; Castaño M
    Ann Ist Super Sanita; 1997; 33(4):581-5. PubMed ID: 9616968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of host factors on survival in dogs with malignant mammary gland tumors.
    Philibert JC; Snyder PW; Glickman N; Glickman LT; Knapp DW; Waters DJ
    J Vet Intern Med; 2003; 17(1):102-6. PubMed ID: 12564734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998-2002).
    Chang SC; Chang CC; Chang TJ; Wong ML
    J Am Vet Med Assoc; 2005 Nov; 227(10):1625-9. PubMed ID: 16313041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
    Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
    J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-9 expression in mammary gland tumors in dogs and its relationship with prognostic factors and patient outcome.
    Santos AA; Lopes CC; Marques RM; Amorim IF; Gärtner MF; de Matos AJ
    Am J Vet Res; 2012 May; 73(5):689-97. PubMed ID: 22533401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine mammary gland tumors.
    Sorenmo K
    Vet Clin North Am Small Anim Pract; 2003 May; 33(3):573-96. PubMed ID: 12852237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine tumor development and crude incidence of tumors by breed based on domestic dogs in Gifu prefecture.
    Komazawa S; Sakai H; Itoh Y; Kawabe M; Murakami M; Mori T; Maruo K
    J Vet Med Sci; 2016 Sep; 78(8):1269-75. PubMed ID: 27150207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of spaying and timing of spaying on survival of dogs with mammary carcinoma.
    Sorenmo KU; Shofer FS; Goldschmidt MH
    J Vet Intern Med; 2000; 14(3):266-70. PubMed ID: 10830539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of Canine Mammary Tumor Histologic Subtypes: An Observational Cohort Study of 229 Cases.
    Rasotto R; Berlato D; Goldschmidt MH; Zappulli V
    Vet Pathol; 2017 Jul; 54(4):571-578. PubMed ID: 28355108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs.
    de Araújo MR; Campos LC; Ferreira E; Cassali GD
    J Vet Intern Med; 2015; 29(5):1360-7. PubMed ID: 26130166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in canine mammary tumors: a multivariate study of 202 consecutive cases.
    Hellmén E; Bergström R; Holmberg L; Spångberg IB; Hansson K; Lindgren A
    Vet Pathol; 1993 Jan; 30(1):20-7. PubMed ID: 8442324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors.
    Moschetta MG; Maschio LB; Jardim-Perassi BV; Gelaleti GB; Lopes JR; Leonel C; Gonçalves Ndo N; Ferreira LC; Martins GR; Borin TF; Zuccari DA
    Oncol Rep; 2015 May; 33(5):2345-53. PubMed ID: 25779537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of SLUG expression in canine mammary gland tumors and its prognostic significance.
    Cheon SB; Kim WH
    BMC Vet Res; 2023 Aug; 19(1):112. PubMed ID: 37553661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative treatment outcome in canine mammary tumors. Multivariate analysis of the prognostic value of pre- and postoperatively available information.
    Betz D; Schoenrock D; Mischke R; Baumgärtner W; Nolte I
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):235-42. PubMed ID: 22911254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and classification for canine and feline mammary gland tumors: a histopathological survey of 437 mammary gland tumor biopsies performed in a secondary care hospital in Chiang Mai, Thailand from 2012 to 2019.
    Srisawat W; Pringproa K; Prachasilchai W; Thongtharb A; Sthitmatee N
    PeerJ; 2024; 12():e17077. PubMed ID: 38500523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors.
    Sarli G; Preziosi R; Benazzi C; Castellani G; Marcato PS
    J Vet Diagn Invest; 2002 Jan; 14(1):25-34. PubMed ID: 12680640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine Mammary Tumors: Comparison of Classification and Grading Methods in a Survival Study.
    Canadas A; França M; Pereira C; Vilaça R; Vilhena H; Tinoco F; Silva MJ; Ribeiro J; Medeiros R; Oliveira P; Dias-Pereira P; Santos M
    Vet Pathol; 2019 Mar; 56(2):208-219. PubMed ID: 30381007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.